Literature DB >> 1515374

Gender and the familial risk for schizophrenia. Disentangling confounding factors.

J M Goldstein1, S V Faraone, W J Chen, M T Tsuang.   

Abstract

Recent studies of the effect of gender on the familial risk for schizophrenia have shown that relatives of females have a higher risk for schizophrenia than relatives of males. This study attempts to explain the effect by examining factors found to differentiate schizophrenic men and women and found to be related to the familial risk for schizophrenia. Cox proportional hazard regression model was used to examine the simultaneous effects of age at onset, season of birth, and premorbid history, controlled for symptoms that have been found to differ by gender (dysphoria, paranoia, and flat affect). Results showed that the effect of gender on the transmission of schizophrenia could not be explained by gender differences in age at onset, symptom expression, premorbid history, and winter birth. However, premorbid history had an effect on familial risk independent of gender, indicating that probands with a poor premorbid history had a lower familial risk for schizophrenia than those with a good premorbid history. Implications of the findings are discussed.

Entities:  

Mesh:

Year:  1992        PMID: 1515374     DOI: 10.1016/0920-9964(92)90043-5

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  10 in total

1.  The role of estrogen in schizophrenia.

Authors:  M V Seeman
Journal:  J Psychiatry Neurosci       Date:  1996-03       Impact factor: 6.186

2.  Stratifying empiric risk of schizophrenia among first degree relatives using multiple predictors in two independent Indian samples.

Authors:  Triptish Bhatia; Elizabeth A Gettig; Irving I Gottesman; Jonathan Berliner; N N Mishra; Vishwajit L Nimgaonkar; Smita N Deshpande
Journal:  Asian J Psychiatr       Date:  2016-08-21

Review 3.  Mitochondrial involvement in psychiatric disorders.

Authors:  Ling Shao; Maureen V Martin; Stanley J Watson; Alan Schatzberg; Huda Akil; Richard M Myers; Edward G Jones; William E Bunney; Marquis P Vawter
Journal:  Ann Med       Date:  2008       Impact factor: 4.709

4.  Sex differences in schizophrenia and other psychotic disorders: a 20-year longitudinal study of psychosis and recovery.

Authors:  Linda S Grossman; Martin Harrow; Cherise Rosen; Robert Faull; Gregory P Strauss
Journal:  Compr Psychiatry       Date:  2008-06-03       Impact factor: 3.735

5.  Mitochondrial mutations and polymorphisms in psychiatric disorders.

Authors:  Adolfo Sequeira; Maureen V Martin; Brandi Rollins; Emily A Moon; William E Bunney; Fabio Macciardi; Sara Lupoli; Erin N Smith; John Kelsoe; Christophe N Magnan; Mannis van Oven; Pierre Baldi; Douglas C Wallace; Marquis P Vawter
Journal:  Front Genet       Date:  2012-06-20       Impact factor: 4.599

6.  Family structure and risk factors for schizophrenia: case-sibling study.

Authors:  Jari K Haukka; Jaana Suvisaari; Jouko Lönnqvist
Journal:  BMC Psychiatry       Date:  2004-11-27       Impact factor: 3.630

7.  Jumping on the Train of Personalized Medicine: A Primer for Non-Geneticist Clinicians: Part 2. Fundamental Concepts in Genetic Epidemiology.

Authors:  Aihua Li; David Meyre
Journal:  Curr Psychiatry Rev       Date:  2014-05

8.  Association between mitochondrial DNA variations and schizophrenia in the northern Chinese Han population.

Authors:  Feng-Ling Xu; Mei Ding; Jun Yao; Zhang-Sen Shi; Xue Wu; Jing-Jing Zhang; Hao Pang; Jia-Xin Xing; Jin-Feng Xuan; Bao-Jie Wang
Journal:  PLoS One       Date:  2017-08-28       Impact factor: 3.240

9.  Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review.

Authors:  Susana Ochoa; Judith Usall; Jesús Cobo; Xavier Labad; Jayashri Kulkarni
Journal:  Schizophr Res Treatment       Date:  2012-04-08

10.  Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder.

Authors:  Brandi Rollins; Maureen V Martin; P Adolfo Sequeira; Emily A Moon; Ling Z Morgan; Stanley J Watson; Alan Schatzberg; Huda Akil; Richard M Myers; Edward G Jones; Douglas C Wallace; William E Bunney; Marquis P Vawter
Journal:  PLoS One       Date:  2009-03-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.